A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer. (Q42654377)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer. |
scientific article |
Statements
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer (English)
Figg WD
Dahut W
Duray P
Hamilton M
Tompkins A
Steinberg SM
Jones E
Premkumar A
Linehan WM
Floeter MK
Chen CC
Dixon S
Kohler DR
Krüger EA
Gubish E
Pluda JM